Stock Rating Upgrade
Of late the Value Trend Rating for Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) improved from C to B reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock declined slightly by -1.0% on 11/15/24. The stock closed at $44.61. This decline was accompanied by normal trading volume. The stock has been strong relative to the market over the last nine months but has declined -3.2% during the last week.
Current PriceTarget Research Rating
Amphastar Pharmaceuticals has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Amphastar Pharmaceuticals has a slightly positive Power Rating of 66 and a slightly positive Appreciation Score of 66, producing the Positive Value Trend Rating.
Be the first to comment